Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation 20147/745, for its state-of-the-art Aveta Hysteroscopy System.

Meditrina, a leader in gynecologic medical devices, announced the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.

Stereotaxis announced that it has entered into a definitive share purchase agreement under which Stereotaxis will acquire Access Point Technologies EP, a privately-held Minnesota-based developer of innovative electrophysiology catheters.

Senseonics Holdings, Inc. in partnership with our global commercial partner, Ascensia Diabetes Care, and St. Louis-based Mercy, a leading health care system and accountable care organization, announced a first-of-its-kind relationship in a diabetes population management program.

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, reported financial results for the quarter ended March 31, 2024.

Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.